Literature DB >> 16483266

Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease--Bilitec, intraluminal impedance and Bravo capsule pH monitoring.

I Hirano1.   

Abstract

Ambulatory pH monitoring detects abnormal levels of acid reflux in the oesophagus and can be used to correlate patients' symptoms with oesophageal acid exposure. Catheter-based pH testing has several limitations, including issues of sensitivity, specificity, tolerability and the inability to record non-acid reflux events. In an effort to improve upon these drawbacks, several devices have been introduced, including the Bilitec system for measuring duodenogastro-oesophageal reflux; intraluminal impedance monitoring, which detects the distribution, composition and clearing of both acid and non-acid oesophageal reflux; and a wireless pH monitoring device, the Bravo capsule. Initial investigations using the Bilitec system demonstrated that duodenogastro-oesophageal reflux tracked very closely with acid reflux and decreased with proton-pump inhibitor (PPI) therapy, casting doubt on the clinical utility of Bilitec monitoring. Recent evidence revealed a possible role for duodenogastro-oesophageal reflux in a subset of patients who continue to report reflux symptoms in the setting of normalized oesophageal acid exposure on high-dose PPI therapy. When combined with pH monitoring, impedance monitoring enhances the detection and characterization of gastro-oesophageal reflux and may have a role in the evaluation of certain specific gastro-oesophageal reflux disease (GERD) symptoms that persist despite acid suppression therapy. The utility of the Bravo wireless technology for GERD diagnosis has been validated in several studies, with improvements over catheter-based pH monitoring in tolerability, accuracy and sensitivity, as well as the ability to record periods both off and on PPI therapy in a single study. All three diagnostic modalities have advanced the understanding of GERD pathogenesis, but their impact on the clinical management of GERD is still the focus of active investigation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16483266     DOI: 10.1111/j.1365-2036.2006.02800.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

Review 1.  New esophageal function testing (impedance, Bravo pH monitoring, and high-resolution manometry): clinical relevance.

Authors:  Jason A Wilson; Marcelo F Vela
Journal:  Curr Gastroenterol Rep       Date:  2008-06

2.  Comparison of the multichannel intraluminal impedance pH and conventional pH for measuring esophageal acid exposure: a propensity score-matched analysis.

Authors:  Masato Hoshino; Nobuo Omura; Fumiaki Yano; Kazuto Tsuboi; Se Ryung Yamamoto; Shunsuke Akimoto; Takahiro Masuda; Hideyuki Kashiwagi; Katsuhiko Yanaga
Journal:  Surg Endosc       Date:  2017-05-18       Impact factor: 4.584

3.  Bravo capsule system optimizes intragastric pH monitoring over prolonged time: effects of ghrelin on gastric acid and hormone secretion in the rat.

Authors:  Tobias Rudholm; Per-Mikael Hellstrom; Elvar Theodorsson; Colin-Allan Campbell; Peter-Geoffrey McLean; Erik Naslund
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

4.  Gastroesophageal reflux disease and tooth erosion.

Authors:  Sarbin Ranjitkar; John A Kaidonis; Roger J Smales
Journal:  Int J Dent       Date:  2011-12-12

5.  Is Wireless Capsule pH Monitoring Better Than Catheter Systems?

Authors:  Joon Seong Lee
Journal:  J Neurogastroenterol Motil       Date:  2012-04-09       Impact factor: 4.924

Review 6.  [Intraoperative Aspiration].

Authors:  Yiyao Cui; Yong Cui
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-05-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.